BIMI (BIMI Holdings) EBIT: $-11.14 Mil (TTM As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIMI BIMI Holdings Inc BIMI
16 GF Score
Price $0.00
View Full Analysis

What is BIMI Holdings EBIT?

BIMI Holdings BIMI 16 EBIT is $-11.14 Mil as of Sep. 2023. GuruFocus rates BIMI with a GF Score™ of 16/100.

BIMI Holdings's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2023 was $-3.10 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2023 was $-11.14 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. BIMI Holdings's annualized ROC % for the quarter that ended in Sep. 2023 was -61.96%. BIMI Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -135.86%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. BIMI Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -1,114,200.00%.

BIMI Holdings  (OTCPK:BIMI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

BIMI Holdings's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

ROC % (Q: Sep. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Sep. 2023 ))/ count )
=-12.6 * ( 1 - 0% )/( (20.88 + 19.792)/ 2 )
=-12.6/20.336
=-61.96 %

where

Invested Capital(Q: Jun. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=36.658 - 13.846 - ( 1.932 - max(0, 19.391 - 25.995+1.932))
=20.88

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=35.041 - 14.255 - ( 0.994 - max(0, 20.158 - 24.367+0.994))
=19.792

Note: The Operating Income data used here is four times the quarterly (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

BIMI Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Sep. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-12.392/( ( (4.526 + max(5.208, 0)) + (4.579 + max(3.929, 0)) )/ 2 )
=-12.392/( ( 9.734 + 8.508 )/ 2 )
=-12.392/9.121
=-135.86 %

where Working Capital is:

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.38 + 7.183 + 9.149) - (13.846 + 0.525 + 3.133)
=5.208

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.116 + 7.087 + 10.885) - (14.255 + 0.762 + 3.142)
=3.929

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

BIMI Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2023 )
=-11.142/0.001
=-1,114,200.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BIMI Holdings EBIT Related Terms

BIMI Holdings EBIT Historical Data

* Premium members only.

The historical data trend for BIMI Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BIMI Holdings EBIT Chart

BIMI Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 -1.53 -3.27 -32.22 -18.19

BIMI Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.29 -8.43 -0.83 1.21 -3.10

BIMI vs RADCQ, HEWA, SSY: EBIT Comparison

For the Pharmaceutical Retailers subindustry, BIMI Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BIMI Holdings EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where BIMI Holdings's EV-to-EBIT falls into.


BIMI
16GF Score
BIMI Holdings Inc BIMI
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BIMI Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-11.14 Mil mean?
BIMI Holdings (BIMI) has a EBIT of $-11.14 Mil as of Sep. 2023. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on BIMI Holdings.
Is BIMI Holdings' EBIT too high?
BIMI Holdings' current EBIT is $-11.14 Mil. Overall, BIMI Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does BIMI Holdings' EBIT compare to RADCQ and HEWA?
BIMI Holdings' EBIT of $-11.14 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on BIMI Holdings. BIMI Holdings's current EBIT is $-11.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BIMI Holdings stock overvalued right now?
BIMI Holdings (BIMI) has a current EBIT of $-11.14 Mil. The current EBIT is $-11.14 Mil. BIMI Holdings' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For BIMI Holdings (BIMI), the current EBIT is $-11.14 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BIMI Holdings Business Description

Address 725 5th Avenue, 15th Floor, 15-01, New York, NY, USA, 10022
BIMI Holdings Inc is a healthcare products and services provider, offering a broad range of healthcare products and related services in the U.S. and Asia. It operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and OTC medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. Medical services include private comprehensive hospitals operating in China.
16GF Score

Get the complete analysis for BIMI

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price